U. S. Securities and Exchange Commission
                             Washington, D.C. 20549

                                   FORM 10-QSB

(Mark One)

[X]  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
     OF 1934

     For the quarter ended October 31, 2002
                           ----------------

[ ]  TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934

For the transition period from ____________ to ____________

                          Commission File No. 000-32089
                                              ---------

                                 FAR GROUP INC.
                  --------------------------------------------
                 (Name of Small Business Issuer in its Charter)

Washington                                                            91-2023071
----------                                                            ----------
(State or Other Jurisdiction of                                 (I.R.S. Employer
incorporation or  organization)                               Identification No)

                          1286 Homer Street, 4th Floor
                   Vancouver, British Columbia, Canada V6B 2Y5
                   -------------------------------------------
                    (Address of Principal Executive Offices)

                                 (604) 689-5255
                            -------------------------
                            Issuer's Telephone Number

                                       N/A
           -----------------------------------------------------------
          (Former Name or Former Address, if changed since last Report)

Check  whether  the Issuer (1) filed all reports required to be filed by Section
13  or  15(d) of the Exchange Act during the past 12 months (or for such shorter
period  that  the  Company  was required to file such reports), and (2) has been
subject  to  such  filing  requirements  for  the  past  90  days.

                    (1)     Yes X   No     (2)     Yes X   No
                               ---    ---             ---    ---

     (ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)

                                 Not applicable

                     (APPLICABLE ONLY TO CORPORATE ISSUERS)

State the number of shares outstanding of each of the Issuer's classes of common
equity,  as  of  the  latest  practicable  date:

                                November 25, 2002

                        Common - 15,850,000 common shares

                       DOCUMENTS INCORPORATED BY REFERENCE

A  description of any "Documents Incorporated by Reference" is contained in Item
6  of  this  Report.

    Transitional Small Business Issuer Format     Yes X     No
                                                     ---      ---


<PAGE>
PART  I - FINANCIAL  INFORMATION

Item  1.  Financial  Statements.

The  Financial  Statements  of the Company required to be filed with this 10-QSB
Quarterly Report were prepared by management and commence on the following page,
together  with  related  notes.  In  the  opinion  of  management, the Financial
Statements  fairly  present  the  financial  condition  of  the  Company.

<TABLE>
<CAPTION>
FAR Group, Inc.
(A Development Stage Company)
Interim Balance Sheet


                                                                                October 31,    April 30,
                                                                                   2002          2002
                                                                                     $             $
                                                                                (unaudited)    (audited)
<S>                                                                            <C>            <C>
ASSETS

Current Assets

Cash                                                                                218,425       4,645
--------------------------------------------------------------------------------------------------------

Total Assets                                                                        218,425       4,645
========================================================================================================

LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities

Accounts payable                                                                     22,880      33,750
Accrued liabilities                                                                     600         550
Note payable (Note 4)                                                                     -      35,000
--------------------------------------------------------------------------------------------------------

Total Liabilities                                                                    23,480      69,300
--------------------------------------------------------------------------------------------------------

Contingency (Note 1)

Stockholders' Equity

Common Stock: $0.0001 par value; authorized 100,000,000 common shares;
15,850,000 and 15,600,000 shares issued and outstanding respectively (Note 5)         1,585       1,560

Additional Paid-in Capital                                                          309,415      24,440
--------------------------------------------------------------------------------------------------------

                                                                                    311,000      26,000
--------------------------------------------------------------------------------------------------------
Preferred Stock: $.0001 par value; authorized 20,000,000 preferred shares;
none issued                                                                               -           -
--------------------------------------------------------------------------------------------------------
Deficit Accumulated During the Development Stage                                   (116,055)    (90,655)
--------------------------------------------------------------------------------------------------------
Total Stockholders' Equity                                                          194,945     (64,655)
--------------------------------------------------------------------------------------------------------
Total Liabilities and Stockholders' Equity                                          218,425       4,645
========================================================================================================
</TABLE>

(See Accompanying Notes to the Interim Financial Statements)


<PAGE>
<TABLE>
<CAPTION>
FAR Group, Inc.
(A Development Stage Company)
Interim Statements of Operations
(unaudited)

                                        Accumulated
                                           From
                                       March 24, 2000          Three Months Ended             Six Months Ended
                                    (Date of Inception)    October 31,    October 31,    October 31,    October 31,
                                       to October 31,
                                            2002              2002           2001           2002           2001
                                             $                  $              $              $              $
<S>                                 <C>                   <C>            <C>            <C>            <C>
Revenue                                               -
--------------------------------------------------------------------------------------------------------------------

Expenses

Accounting and legal                             52,265          5,092         10,022         17,681         13,277
Business development                              5,000              -              -          5,000              -
Consulting fees                                  15,000              -          2,500              -          2,500
License written-off                              35,000              -              -              -              -
Office                                            2,791            876           (139)         1,274            309
Transfer agent and filing fees                    5,999            663            768          1,445          1,626
--------------------------------------------------------------------------------------------------------------------

Net loss                                       (116,055)        (6,631)       (13,151)       (25,400)       (17,712)
====================================================================================================================

Net Loss Per Share                                                   -              -              -              -
====================================================================================================================
Weighted Average Number of Shares
Outstanding (stock split applied
retroactively)                                              15,850,000     15,600,000     15,737,000     15,600,000
====================================================================================================================
</TABLE>

(Diluted loss per share has not been presented as the result is anti-dilutive)


(See Accompanying Notes to the Interim Financial Statements)


<PAGE>
<TABLE>
<CAPTION>
FAR Group, Inc.
(A Development Stage Company)
Interim Statements of Cash Flows
(unaudited)

                                                                      Six Months Ended
                                                                  October 31,    October 31,
                                                                     2002           2001
                                                                       $              $
<S>                                                              <C>            <C>
Cash Flows From Operating Activities

Net loss                                                              (25,400)       (17,712)

Changes in operating assets and liabilities:

Prepaid expense                                                             -         (7,500)
Accounts payable and accrued liabilities                              (10,820)        28,101
---------------------------------------------------------------------------------------------
Net Cash Used by Operating Activities                                 (36,220)         2,889
---------------------------------------------------------------------------------------------
Cash Flows From Financing Activities

Common shares issued                                                  250,000              -
---------------------------------------------------------------------------------------------

Increase In Cash                                                      213,780          2,889

Cash - Beginning of Period                                              4,645          2,361
---------------------------------------------------------------------------------------------
Cash - End of Period                                                  218,425          5,250
=============================================================================================

Non-Cash Financing Activities

A $35,000 note payable was assumed by the Company for the
acquisition of a License from a director which was forgiven on
July 12, 2002 (Notes 3 and 4)                                               -              -
=============================================================================================

Supplemental Disclosures

Interest paid                                                               -              -
Income tax paid                                                             -              -
</TABLE>

(See Accompanying Notes to the Interim Financial Statements)


<PAGE>
FAR  Group,  Inc.
A  Development  Stage  Company)
Notes to the Interim Financial Statements
October  31,  2002
(unaudited)

1.   Development Stage Company

     FAR  Group,  Inc.  herein  (the "Company") was incorporated in the State of
     Washington,  U.S.A.  on  March  24, 2000. The Company acquired a license to
     market  and  distribute  vitamins,  minerals,  nutritional supplements, and
     other  health  and  fitness  products  in  which the grantor of the license
     offers  these  products  for sale from various suppliers on their Web Site.
     The  Company is currently developing a marketing strategy to offer personal
     care  products  through a kiosk-based ordering system. Once the kiosk-based
     marketing  strategy  is  developed,  it  will serve as another distribution
     network  for  both  of  its  product  lines.

     The  Company  is  in the development stage. In a development stage company,
     management  devotes  most  of its activities in developing a market for its
     products.  Planned  principal activities have not yet begun. The ability of
     the  Company  to  emerge  from  the  development  stage with respect to any
     planned  principal  business  activity  is  dependent  upon  its successful
     efforts  to  raise  additional  equity  financing  and/or attain profitable
     operations.  There  is  no guarantee that the Company will be able to raise
     any  equity  financing  or  sell  any of its products at a profit. There is
     substantial  doubt  regarding  the Company's ability to continue as a going
     concern.

     The  Company  filed an SB-2 Registration Statement with the U.S. Securities
     Exchange  Commission  which  was declared effective in January 2001. During
     fiscal  2001,  the Company sold and issued 1,000,000 common shares at $0.01
     per  share  for  cash  proceeds  of  $10,000. During the fiscal period, the
     Company,  pursuant  to a private placement, issued 250,000 common shares at
     $1.00  per  share  for cash proceeds of $250,000. The Company trades on the
     OTC  Bulletin  Board  under  the  symbol  FGRI.


2.   Summary of Significant Accounting Policies

     (a)  Year end

          The  Company's  fiscal  year  end  is  April  30.

     (b)  License

          The  cost  to  acquire  the  License  was  initially  capitalized. The
          carrying value of the License is evaluated in each reporting period to
          determine if there were events or circumstances which would indicate a
          possible  inability to recover the carrying amount. Such evaluation is
          based on various analyses including assessing the Company's ability to
          bring  the  commercial  applications  to market, related profitability
          projections  and  undiscounted cash flows relating to each application
          which  necessarily  involves significant management judgment. Where an
          impairment  loss  has  been  determined  the  carrying  amount  is
          written-down  to fair market value. Fair market value is determined as
          the amount at which the license could be sold in a current transaction
          between  willing  parties.  The  License  has  been  written-off  to
          operations  due to the lack of historical cash flow of the license and
          lack  of  a  market  to  resell  the  license.

     (c)  Cash and Cash Equivalents

          The Company considers all highly liquid instruments with a maturity of
          three  months  or less at the time of issuance to be cash equivalents.

     (d)  Revenue Recognition

          The  Company will receive from the Grantor of the license, commissions
          of  one-half of all the profit on all sales made through the Grantor's
          Web  Site. The commission revenue will be recognized in the period the
          sales have occurred. The Company will report the commission revenue on
          a  net  basis as the Company is acting as an Agent for the Grantor and
          does not assume any risks or rewards of the ownership of the products.
          This  policy  is  prospective  in  nature  as  the Company has not yet
          generated  any  revenue.


<PAGE>
2.   Summary of Significant Accounting Policies

     (e)  Use of Estimates

          The  preparation  of financial statements in conformity with generally
          accepted  accounting  principles requires management to make estimates
          and  assumptions  that  affect  the  reported  amounts  of  assets and
          liabilities and disclosure of contingent assets and liabilities at the
          date  of the financial statements and the reported amounts of revenues
          and  expenses  during  the  periods.  Actual results could differ from
          those  estimates.

     (f)  Interim Financial Statements

          These interim unaudited financial statements have been prepared on the
          same  basis  as  the annual financial statements and in the opinion of
          management,  reflect  all  adjustments,  which  include  only  normal
          recurring  adjustments,  necessary  to  present  fairly  the Company's
          financial  position,  results  of  operations  and  cash flows for the
          periods  shown.  The  results  of  operations for such periods are not
          necessarily  indicative of the results expected for a full year or for
          any  future  period.

     (g)  Recent Accounting Pronouncements

          On  June 29, 2001, SFAS No. 141, "Business Combinations," was approved
          by  the  Financial  Accounting  Standards Board ("FASB"). SFAS No. 141
          requires  that  the  purchase  method  of  accounting  be used for all
          business  combinations  initiated  after  June  30, 2001. Goodwill and
          certain  intangible assets will remain on the balance sheet and not be
          amortized.  On  an  annual  basis, and when there is reason to suspect
          that  their values have been diminished or impaired, these assets must
          be  tested  for  impairment,  and  write-downs  may  be necessary. The
          Company implemented SFAS No. 141 on July 1, 2001 and its impact is not
          expected  to  be  material  on  its  financial  position or results of
          operations.

          On  June  29,  2001,  SFAS  No.  142,  "Goodwill  and Other Intangible
          Assets," was approved by FASB. SFAS No. 142 changes the accounting for
          goodwill  from  an amortization method to an impairment-only approach.
          Amortization of goodwill, including goodwill recorded in past business
          combinations,  will cease upon adoption of this statement. The Company
          adopted  SFAS  No. 142 on April 1, 2002 and its impact is not expected
          to  have  a  material  effect  on its financial position or results of
          operations.

          In  June  2001,  the  FASB  issued SFAS No. 143, "Accounting for Asset
          Retirement  Obligation."  SFAS  No.  143 is effective for fiscal years
          beginning  after June 15, 2002, and will require companies to record a
          liability for asset retirement obligations in the period in which they
          are  incurred,  which  typically  could  be upon completion or shortly
          thereafter.  The  FASB decided to limit the scope to legal obligations
          and  the  liability  will  be  recorded  at  fair value. The effect of
          adoption  of  this standard on the Company's results of operations and
          financial  positions  is  being  evaluated.

          In  August  2001,  the  FASB  issued SFAS No. 144, "Accounting for the
          Impairment  or  Disposal  of  Long-Lived  Assets."  SFAS  No.  144  is
          effective  for  fiscal  years  beginning  after  December 15, 2001. It
          provides  a  single  accounting  model  for  long-lived  assets  to be
          disposed  of  and replaces SFAS No. 121 "Accounting for the Impairment
          of  Long-Lived  Assets  and  Long-Lived Assets to Be Disposed Of." The
          Company  adopted SFAS No. 144 on April 1, 2002. The effect of adoption
          of  this standard on the Company's results of operations and financial
          position  is  not  expected  to  be  material.

          In  June  2002,  FASB  issued  SFAS  No.  146,  "Accounting  for Costs
          Associated  with  Exit or Disposal Activities". The provisions of this
          Statement  are  effective  for  exit  or  disposal activities that are
          initiated  after December 31, 2002, with early application encouraged.
          This  Statement addresses financial accounting and reporting for costs
          associated  with  exit  or  disposal activities and nullifies Emerging
          Issues  Task  Force  (EITF) Issue No. 94-3, "Liability Recognition for
          Certain  Employee  Termination  Benefits  and  Other  Costs to Exit an
          Activity  (including Certain Costs Incurred in a Restructuring)". This
          Statement requires that a liability for a cost associated with an exit
          or disposal activity be recognized when the liability is incurred. The
          Company  will  adopt  SFAS  No.  146 on January 1, 2003. The effect of
          adoption  of  this standard on the Company's results of operations and
          financial  position  is  being  evaluated.


<PAGE>
          FASB  has  also issued SFAS No. 145 and 147 but they will not have any
          relationship  to the operations of the Company therefore a description
          of  each  and their respective impact on the Company's operations have
          not  been  disclosed.


3.   License

     The  Company's asset is a license to market vitamins, minerals, nutritional
     supplements and other health and fitness products through the Grantor's Web
     Site.  The  Company  desires  to  market  these  products  to  medical
     practitioners,  alternative  health professionals, martial arts studios and
     instructors,  sports  and  fitness  trainers,  other  health  and  fitness
     practitioners,  school  and  other  fund raising programs and other similar
     types of customers in Minnesota. The license was acquired on April 13, 2000
     and  renewed on August 15, 2002 for a term of three years. The Company must
     pay  an  annual  fee  of  $500  for  maintenance  of the Grantor's Web Site
     commencing  with  the  year  ended  April  13, 2002. The Grantor waived the
     annual fee due on April 13, 2001. The Grantor of the license retains 50% of
     the  profits.

     The Company paid total consideration of $35,000 for the license with a note
     payable  of  $35,000.  See  Note  4.

     The  License  was  written-off  to operations due to the lack of historical
     cash  flow  and  lack of a market to resell the license. However, it is the
     Company's intention to conduct a survey to determine its core target market
     from  amongst  the potential clients under its Vitamineralherb.com license,
     hire  commissioned  sales  staff, establish an office, advertise, and begin
     making  sales.


4.   Related  Party  Transaction

     The License referred to in Note 3 was assigned to the Company by the former
     sole  director and former President of the Company for consideration of the
     assumption of a note payable of $35,000 to Vitamineralherb.com. The License
     was  recorded  at  the  transferor's  cost  of $35,000, which was also fair
     market  value at the time. The Grantor of the License is not related to the
     Company.  On  December  12,  2000,  on  behalf  of  the Company, the former
     President of the Company repaid the note payable to Vitamineralherb.com for
     which  the Company issued a note payable of $35,000 to the former President
     of  the  Company.  The  $35,000 note payable to the former President of the
     Company  was  unsecured, non-interest bearing and was repayable by December
     31, 2010. On July 12, 2002, the former President of the Company forgave the
     note  payable  and  released  the  Company from all obligations. Due to his
     relationship  to  the  Company  as the principal stockholder at the time of
     forgiveness,  the  forgiveness of this debt has been treated as contributed
     capital,  in  accordance  with  the provisions of Staff Accounting Bulletin
     Topic  5T.


5.   Common Stock

     (a)  The  Company's Board of Directors approved a six for one forward split
          with  a  record  date  of  August  31,  2001.

     (b)  During the fiscal period ended October 31, 2002, pursuant to a private
          placement, the Company issued 250,000 common shares at $1.00 per share
          for  total  cash  consideration  of  $250,000.


Item  2.  Management's Discussion and Analysis or Plan of Operation
-------------------------------------------------------------------

The  following  discussion  and  analysis of FAR Group's financial condition and
results  of  operations  should  be  read  in  conjunction with the accompanying
financial  statements  and  notes  and the other financial information appearing
elsewhere  in  this  report.  This  Report  contains statements that may contain
forward-looking  statements,  concerning  the  Company's  future  operations and
planned  future acquisitions and other matters and the Company intends that such
forward-looking  statements  be subject to the safe harbors for such statements.
Any  statements  that  involve  discussions  with  respect  to  predictions,
expectations,  belief,  plans,  projections,  objectives,  assumptions or future
events  or performances (often, but not always, using phrases such as "expects",
or  "does  not  expect",  "is expected", "anticipates" or "does not anticipate",
"plans",  "estimates",  or "intends", or stating that certain actions, events or
results  "may",  "could",  or "might" or "will" be taken to occur or be achieved
are not statements of historical fact and may be "forward looking statements".


<PAGE>
The  Company  cautions  readers  not  to  place  undue  reliance  on  any  such
forward-looking  statements  which  speak  only  as  of  the  date  made.  Such
forward-looking  statements  are  based  on  the  beliefs  and  estimates of the
Company's management as well as on assumptions made by and information currently
available to the Company at the time such statements were made.  Forward-looking
statements are subject to a variety of risks and uncertainties which could cause
actual  events  or results to differ from those reflected in the forward-looking
statements,  including,  without  limitation,  the  failure  to  obtain adequate
financing  on  a timely basis and other risks and uncertainties.  Actual results
could  differ materially from those projected in the forward-looking statements,
either  as  a  result  of  the  matters set forth or incorporated in this Report
generally and certain economic and business factors, some of which may be beyond
the  control  of  the  Company.

CRITICAL  ACCOUNTING  POLICIES
------------------------------

The Company's discussions and analysis of its financial condition and results of
operations,  including  the  discussion  on  liquidity and capital resources are
based  upon  the  Company's  financial  statements,  which have been prepared in
accordance with US GAAP.  The preparation of these financial statements requires
the Company to make estimates and judgements that affect the reported amounts of
assets, liabilities, revenues and expenses, and related disclosure of contingent
assets  and  liabilities.  On  an  ongoing  basis,  management  re-evaluates its
estimates and judgements, particularly those related to the determination of the
impairment  of  its  intangible  assets.

PLAN  OF  OPERATION
-------------------

During  the  period  from  March 24 2000 through October 31, 2002, FAR Group has
engaged  in  no  significant  operations  other  than organizational activities,
acquisition  of  the  rights  to  market  Vitamineralherb,  preparation  for
registration  of  its  securities  under the Securities Act of 1933, as amended,
preparation  of a supplementary business plan and completing a private placement
to  fund  this secondary division. No revenues were received by FAR Group during
this  period.

The  original  shareholder  paid  legal expenses upon inception in the amount of
$16,000 for which he received 1,600,000 shares of common stock of the Company.

The  Company  filed  an  SB-2  Registration  Statement  with the U.S. Securities
Exchange  Commission  which  was declared effective in January 2001. The Company
sold  and issued 1,000,000 common shares at $0.01 per share for cash proceeds of
$10,000.  The  Company  trades  on the OTC Bulletin Board under the symbol FGRI.

During  the  period  just  ended,  the  Company  extended  its  license  with
Vitamineralherb.com  for an additional three years to market vitamins, minerals,
nutritional  supplements  and  other  health  and  fitness products in Minnesota
through  the Vitamineralherb.com web site.  The license is now valid until April
2006  subject  to  the  payment  of  the  annual  fees.

FAR  Group's  business  plan  in  connection  with  the license to sell products
through  the  Vitamineralherb.com  web  site was to determine the feasibility of
selling products to targeted markets.   In order to determine the feasibility of
its  business plan, FAR Group plans for the next six months, to conduct research
into these various potential target markets. Should FAR Group determine that the
exploitation  of  the  license is feasible, it will engage salespeople to market
the  products.  Based  primarily  on  discussions  with  the licensor, FAR Group
believes  that  during  its  first  operational  quarter, it will need a capital
infusion  of  approximately  $85,000  to achieve a sustainable sales level where
ongoing  operations  can  be  funded  out  of revenues. This capital infusion is
intended  to  cover costs of advertising, hiring and paying two salespeople, and
administrative expenses. In addition, FAR Group will need approximately $260,000
in  the  event it determines that its market will not pay in advance and it will
have  to  extend  credit.  FAR  Group  will  have to obtain additional financing
through  an  offering  or  capital  contributions  by  current shareholders. The
implementation  of FAR Group's initial plans were delayed as Vitamineralherb.com
re-worked  its  web  site rendering it non-operational for a period of time.  In
addition,  Vitamineralherb  changed  its  primary  supplier  of  products  again
delaying  FAR  Group's  ability  to  initiate  its  business  plan.

In  addition  to  its  Vitamineralherb business development, during the previous
quarter  ended July 31, 2002, FAR Group initiated the development of a marketing
strategy  to  offer  consumers  high  quality,  competitive priced personal care
products  through a kiosk-based ordering system with additional website, mail-in
and  phone  orders.  Once  developed, the Company intends to use the kiosk-based
marketing  strategy as another distribution network for both its Vitamineralherb
products and the products of Health Anti-Aging Lifestyle Options, Inc. ("HALO").
Upon  completion  of  the  development  of its kiosk based marketing system, the
Company  intends  to enter into a marketing partnership with HALO to sell HALO's
health  and wellness products.  There can be no assurances that the Company will
be  successful in developing its kiosk based marketing system or that it will be
able  to  secure  products  for  distribution  through  this  system.


<PAGE>
The  implementation of this development has been delayed to enable FAR to secure
additional  products  for  distribution  as HALO has ceased to sell the products
that  they  were  previously  marketing  and  is  now  seeking  new  products to
represent.

The  company had total general and administrative expenses of $25,400 in the 2nd
Quarter  2002,  compared  to  $17,712  in  the  2nd quarter 2001, an increase of
$7,688.  The  increase  was primarily due to additional legal and administrative
costs relating to the private placement with HALO.  The company also incurred an
additional  cost  of  $5,000  relating  to  the  preparation  of the kiosk-based
marketing  strategy  business  plan.

For  the  remainder  of the current fiscal year ending April 30, 2003, FAR Group
anticipates  incurring a loss as a result of expenses associated with setting up
a  company  structure  to  begin  implementing  its  business  plans.  FAR Group
anticipates  that  until  these  procedures  are completed, it will not generate
revenues,  and  may continue to operate at a loss thereafter, depending upon the
performance  of  the  business.

FAR  Group  remains  in  the  development stage. FAR Group's balance sheet as of
October  31, 2002 reflects total assets of $ 218,425 comprising of all cash. The
Company  had  total liabilities of $23,480 of which $22,000 represented advances
from  a  shareholder to cover the Company's operating expenses in the past.  The
Company  has  incurred  a  loss  of $ 25,400 for the fiscal period to date and a
total  loss  of  $116,055  from inception.  During the quarter ended October 31,
2002,  the  Company  did  not  issue  any  of common stock.  During the previous
quarter, the Company issued 250,000 common shares to HALO on a private placement
basis  for  proceeds  of $250,000.  The proceeds from this private placement are
intended  for  general working capital in connection with the development of its
kiosk  based  marketing  system and none of the proceeds are intended to be used
towards  the  Vitamineralherb  segment  of  the  Company's  business.

Liquidity
---------

The  Company  had  cash  on hand of $ 218,425 as at October 31, 2002 and working
capital of $194,945 as compared to cash on hand of $4,645 and a negative working
capital of $64,655 as at April 30, 2002.  The change in working capital and cash
was due primarily to the private placement of 250,000 common shares completed in
July  2002.  The  Company  believes  that  it  has  sufficient funds to meet its
administrative  operating  obligations  for  the next twelve months however, the
Company  has  allocated  a  significant  portion  of the cash on hand to working
capital  for  the  development  of  the  kiosk  marketing  system  and  related
administrative  costs.

FAR  Group  will need additional capital to carry out all of its obligations and
business  strategies.  The  Company  intends  to  raise  any  additional capital
required  to  fund  its  financing  needs  by  issuance of debt and equity.  The
Company's  management  has  been exploring a number of other options to meet the
Company's obligations and future capital requirements, including the possibility
of  equity  offering, debt financing, and business combination.  There can be no
assurance  financing  will  be  available  or  accessible  on  reasonable terms.

FAR  Group  may  engage  in  a  combination with another business. FAR Group has
engaged  in  discussions concerning potential business combinations, but has not
entered  into  any  agreement  for  such  a  combination.

FAR  Group's  failure  to  generate  revenues  and  conduct operations since its
inception  raise  substantial  doubt  about FAR Group's ability to continue as a
going concern. FAR Group will require substantial working capital, and currently
has inadequate capital to fund all of its business strategies.  FAR Group may be
unable  to  raise  the  funds  necessary  for  implementing  all of its business
strategies,  which  could  severely  limit  its  operations.

Item  3.  Controls  and  Procedures
-----------------------------------

The  Company  maintains  disclosure controls and procedures that are designed to
ensure  that  information  required  to be disclosed in the Company's Securities
Exchange  Act  of  1934  reports is recorded, processed, summarized and reported
within  the  time  periods specified in the SEC's rules and forms, and that such
information  is  accumulated  and  communicated  to  the  Company's  management
including  its  Chief  Executive  Officer  and  Chief  Financial  Officer,  as
appropriate,  to  allow  timely  decisions  regarding  required  disclosure.

Within  90  days  prior  to  the  date  of this report, the Company's management
carried  out  an  evaluation under the supervision and with the participation of
the  Company's  management,  including the Company's Chief Executive Officer and
Chief Financial Officer, of the effectiveness of the design and operation of the


<PAGE>
Company's  disclosure  controls  and  procedures  pursuant  to Exchange Act Rule
13a-14.  Based  upon  the  foregoing,  the Company's Chief Executive Officer and
Chief  Financial  Officer  concluded  that the Company's disclosure controls and
procedures  are effective in connection with the filing of this Quarterly Report
on  Form  10-QSB  for  the  quarter  ended  October  31,  2002.

There  were  no  significant changes in the Company's internal controls or other
factors that could significantly affect these controls subsequent to the date of
their  evaluation, including any significant deficiencies or material weaknesses
of  internal  controls  that  would  require  corrective  action.


PART  II  -  OTHER  INFORMATION

Item  1.  Legal  Proceedings.

          None;  not  applicable.

Item  2.  Changes  in  Securities.

          None

Item  3.  Defaults  Upon  Senior  Securities.

          None;  not  applicable.

Item  4.  Submission  of  Matters  to  a  Vote  of  Security  Holders.

          None

Item  5.  Other  Information.

          None

Item  6.  Exhibits  and  Reports  on  Form  8-K.

          (a)  Exhibits

               99.1   Section 906 Certification of Chief Executive Officer
                      and Chief Financial Officer

          (b)  Reports  on  Form  8-K

               None

          DOCUMENTS  INCORPORATED  BY  REFERENCE

          None.


<PAGE>
                                   SIGNATURES


Pursuant  to  the  requirements  of  the  Securities  Exchange  Act of 1934, the
Registrant  has  duly  caused  this  Report  to  be  signed on its behalf by the
undersigned  thereunto  duly  authorized.

                                               FAR GROUP INC.



Date:    December 3, 2002                      By:  /s/  Jim Glavas
       --------------------                         ----------------------------
                                                    Jim Glavas
                                                    President, CEO, CFO and
                                                    Director



Date:    December 3, 2002                      By:  /s/  Aaron Kirsten
       --------------------                         ----------------------------
                                                    Aaron Kirsten
                                                    Director




Date:    December 3, 2002                      By:  /s/  Larry Bishop
       --------------------                         ----------------------------
                                                    Larry Bishop
                                                    Director



Pursuant to the requirements of the Securities Exchange Act of 1934, as amended,
this  Report  has  been  signed  below by the following persons on behalf of the
Company  and  in  the  capacities  and  on  the  dates  indicated:




Date:    December 3, 2002                      By:  /s/  Jim Glavas
       --------------------                         ----------------------------
                                                    Jim Glavas
                                                    President, CEO, CFO and
                                                    Director



Date:    December 3, 2002                      By:  /s/  Aaron Kirsten
       --------------------                         ----------------------------
                                                    Aaron Kirsten
                                                    Director




Date:    December 3, 2002                      By:  /s/  Larry Bishop
       --------------------                         ----------------------------
                                                    Larry Bishop
                                                    Director


<PAGE>
                            CERTIFICATION PURSUANT TO
                  SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

     I,  Jim  Glavas, Chief Executive Officer and Chief Financial Officer of FAR
Group  Inc.,  certify  that:

     1.     I  have  reviewed  this Quarterly Report on Form 10-QSB of FAR Group
Inc.;

     2.     Based  on  my  knowledge, this Quarterly Report does not contain any
untrue  statement  of a material fact or omit to state a material fact necessary
to  make  the  statements  made,  in light of the circumstances under which such
statements  were made, not misleading with respect to the period covered by this
Quarterly  Report;

     3.     Based on my knowledge, the financial statements, and other financial
information  included  in  this Quarterly Report, fairly present in all material
respects  the  financial  condition, results of operations and cash flows of the
Registrant as of, and for, the periods presented in this Quarterly Report;

     4.     I  am  responsible  for  establishing  and  maintaining  disclosure
controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for
the  Registrant  and  I  have:

     a)   designed  such  disclosure  controls  and  procedures  to  ensure that
          material  information  relating  to  the  Registrant,  including  its
          consolidated  subsidiaries, is made known to me by others within those
          entities,  particularly  during  the  period  in  which this Quarterly
          Report  is  being  prepared;

     b)   evaluated  the  effectiveness  of the Registrant's disclosure controls
          and procedures as of a date within 90 days prior to the filing date of
          this  Quarterly  Report  (the  "Evaluation  Date");  and

     c)   presented  in  this  Quarterly  Report  our  conclusions  about  the
          effectiveness  of  the  disclosure controls and procedures based on my
          evaluation  as  of  the  Evaluation  Date;

     5.   I  have  disclosed,  based  on  my  most  recent  evaluation,  to  the
Registrant's auditors and the audit committee of Registrant's board of directors
(or  persons  performing  the  equivalent  function);

     a)   all  significant  deficiencies  in the design or operation of internal
          controls  which  could  adversely  affect  the Registrant's ability to
          record,  process,  summarize  and  report  financial  data  and  have
          identified  for  the  Registrant's auditors any material weaknesses in
          internal  controls;  and

     b)   any  fraud, whether or not material, that involves management or other
          employees  who  have  a  significant role in the Registrant's internal
          controls;  and

     6.   I  have  indicated  in this Quarterly Report whether or not there were
significant  changes  in  internal  controls  or  in  other  factors  that could
significantly  affect internal controls subsequent to the date of my most recent
evaluation,  including  any  corrective  actions  with  regard  to  significant
deficiencies  and  material  weaknesses.

Date:  December 3, 2002      Signature:  /s/  Jim Glavas
     --------------------              -----------------------------------------
                                       Jim  Glavas
                                       Chief Executive Officer / Chief Financial
                                       Officer


<PAGE>